Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 3 boards, counting each seat separately. Longest: Puma Biotechnology Inc, 3 years.
Puma Biotechnology Inc
Director
BioCardia Inc.
Director
SiNtx Technologies Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Puma Biotechnology Inc June 11, 202696.5%
-
BioCardia Inc. December 2, 202594.7%
-
Puma Biotechnology Inc June 11, 202598.3%
-
Puma Biotechnology Inc June 18, 202498.2%
-
Puma Biotechnology Inc June 13, 202397.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 12, 2026 | Puma Biotechnology Inc | Open-market sale | −22,000 | $7.22 | $158,840 |
| Jun 11, 2026 | Puma Biotechnology Inc | Grant or award | +27,000 | — | — |
| Feb 23, 2026 | SiNtx Technologies Inc. | Open-market purchase | +1,000 | $2.91 | $2,910 |
| Aug 26, 2025 | SiNtx Technologies Inc. | Open-market purchase | +3,000 | $3.59 | $10,770 |
| Jun 13, 2025 | Puma Biotechnology Inc | Open-market sale | −22,000 | $3.40 | $74,800 |
| Jun 11, 2025 | Puma Biotechnology Inc | Grant or award | +27,000 | — | — |
| Jun 18, 2024 | Puma Biotechnology Inc | Grant or award | +27,000 | — | — |
| Jun 13, 2024 | Puma Biotechnology Inc | Open-market sale | −22,000 | $3.34 | $73,480 |
| Jun 13, 2023 | Puma Biotechnology Inc | Open-market sale | −22,000 | $3.45 | $75,900 |
| Jun 13, 2023 | Puma Biotechnology Inc | Grant or award | +27,000 | — | — |
| Mar 6, 2023 | Sera Prognostics Inc. | Grant or award | +32,800 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.